Cell therapy weekly: Israel and UAE collaborate to develop stem cell therapies against COVID-19

This week: Pluristem (Haifa, Israel) collaborates with Abu Dhabi Stem Cells Center (UAE) to develop stem cell therapies for COVID-19, Oragnicell (FL, USA) initiates Phase I/II clinical trial testing Zofin against COVID-19 and Acepodia (CA, USA) doses first patient in a Phase I study of its NK cell therapy for solid tumors. The news highlights: Israel and UAE collaborate to develop stem cell therapies against COVID-19 Collaboration established to initiate a Phase I/II clinical trial of Zofin against COVID-19 Phase I clinical trial launched to evaluate allogenic NK cell therapy for treatment of solid tumors Israel and UAE collaborate to...